Review
doi: 10.1016/0277-5379(87)90046-0.
TCNU: a ray of hope for designer nitrosoureas?
- PMID: 3325292
- DOI: 10.1016/0277-5379(87)90046-0
Item in Clipboard
Review
TCNU: a ray of hope for designer nitrosoureas?
Eur J Cancer Clin Oncol.
1987 Dec.
No abstract available
Similar articles
-
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.Eur J Cancer Clin Oncol. 1988 Aug;24(8):1361-4. doi: 10.1016/0277-5379(88)90229-5. Eur J Cancer Clin Oncol. 1988. PMID: 3181257
-
Phase II study of TCNU in advanced breast cancer.Eur J Cancer Clin Oncol. 1988 Aug;24(8):1377-8. doi: 10.1016/0277-5379(88)90232-5. Eur J Cancer Clin Oncol. 1988. PMID: 3181260 No abstract available.
-
Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).Invest New Drugs. 1988 Apr;6(1):19-30. doi: 10.1007/BF00170775. Invest New Drugs. 1988. PMID: 3410663
-
Current status of nitrosoureas under development in Japan.Recent Results Cancer Res. 1981;76:115-24. doi: 10.1007/978-3-642-81565-2_10. Recent Results Cancer Res. 1981. PMID: 6453413 Review. No abstract available.
-
Contributions of nitrosoureas to cancer treatment.Cancer Treat Rep. 1986 Jan;70(1):31-41. Cancer Treat Rep. 1986. PMID: 3002621 Review. No abstract available.
Cited by
-
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.Br J Cancer. 1992 Aug;66(2):323-30. doi: 10.1038/bjc.1992.264. Br J Cancer. 1992. PMID: 1503906 Free PMC article.
-
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.Cancer Chemother Pharmacol. 1990;25(5):337-41. doi: 10.1007/BF00686233. Cancer Chemother Pharmacol. 1990. PMID: 2306793